| Value | ₹22.02 Cr |
|---|
BSE filing, NSE: HYUNDAI. Summary written from the filing by ALFA Finder's alert engine.
Hyundai Motor India Ltd: key numbers
- Share price
- ₹1,985.00
- Market cap
- ₹1,61,289 Cr
- Revenue (annual)
- ₹70,763 Cr
- Net profit (annual)
- ₹5,432 Cr
- P/E (TTM)
- 35.3×Sector 31.3×
- Promoter holding
- 82.50%+0.00% QoQ
- FII holding
- 3.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hyundai Motor India Ltd
All →Hyundai Motor India Business Update
Hyundai Motor India reported its highest-ever October 2026 sales of 82,299 units, up 17.7% YoY. The release covers monthly unit sales only, with no monetary figures.
Hyundai Motor India Earnings Call Transcript: Key Takeaways
Hyundai recorded its highest-ever quarterly revenue but faced significant margin pressure from steep raw material inflation and competitive intensity.
Hyundai Motor India Investor Presentation: Key Takeaways
Q2 FY27 record revenue of ₹20,696 Cr (+18.5% YoY) and record 219,072 units (+14.7%). PAT fell 23.9% to ₹1,196 Cr on raw-material cost inflation.
Hyundai Motor India Results Update
Hyundai Motor India approved Q2 FY27 results showing record quarterly sales of 219,072 units and 9.5% EBITDA margin. CEO flagged BAYON launch as the start of a golden product cycle.
Hyundai Motor India Q2 FY27 Results: Net Profit ₹1,196 Cr, Down 23.9% YoY
Hyundai Motor India Ltd reported revenue from operations of ₹20,696 Cr (+18.5% YoY) and net profit of ₹1,196 Cr (-23.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,196 Cr · -23.9% YoY
Hyundai Motor India Product Launch
Hyundai India launched the BAYON mid-size SUV starting at ₹9,99,900. It debuts a Generative AI voice assistant and Level 2 Pro ADAS, targeting 50+ export markets.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.